Sun Pharmaceutical Industries reports 17% rise in Q3 consolidated net profit

31 Jan 2024 Evaluate

Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2023 (Q3FY24). 

The company has reported 48.20% rise in net profit at Rs 721.31 crore for the third quarter ended December 31, 2023 as compared to Rs 486.73 crore for the same quarter in the previous year. Total income of the company increased by 9.27% at Rs 5150.55 crore for Q3FY24 as compared Rs 4713.78 crore for corresponding quarter of the previous year.

On consolidated basis, the company reported 17.42% rise in its net profit at Rs 2560.54 crore for Q3FY24 as compared to Rs 2180.75 crore for the same quarter in the previous year. Total income of the company increased by 10.65% at Rs 12630.90 crore for Q3FY24 as compared Rs 11414.85 crore for corresponding quarter of the previous year.

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×